Beam Therapeutics (BEAM) EBIT Margin Growth (3y) (2022 - 2026)
Beam Therapeutics (BEAM) EBIT Margin Growth (3y) (2022 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EBIT Margin Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
-40,178.00 |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
530.00 |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Beam Therapeutics |
3.53 Bn |
3.53 Bn |
- |
7,085.00 |
| Date | Value |
|---|
| Mar 31, 2026 |
7,085.00 |
| Dec 31, 2025 |
42,882.00 |
| Sep 30, 2025 |
-72,970.00 |
| Jun 30, 2025 |
-92,699.00 |
| Mar 31, 2025 |
-69,287.00 |
| Dec 31, 2024 |
-20,840.00 |
| Sep 30, 2024 |
837,994.00 |
| Jun 30, 2024 |
98.20 Mn |
| Mar 31, 2024 |
333.81 Mn |
| Dec 31, 2023 |
68.00 Mn |
| Sep 30, 2023 |
62.14 Mn |
| Jun 30, 2023 |
43.76 Mn |
| Mar 31, 2023 |
47.22 Mn |
| Dec 31, 2022 |
43.91 Mn |
| Sep 30, 2022 |
29.98 Mn |
| Jun 30, 2022 |
29.37 Mn |
